Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes

被引:45
作者
Friedrich, LV [1 ]
White, RL [1 ]
Bosso, JA [1 ]
机构
[1] Med Univ S Carolina, Coll Pharm, Dept Pharmaceut Sci, Anti Infect Res Lab, Charleston, SC 29425 USA
关键词
D O I
10.1086/514747
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evaluation of antimicrobial usage vs, susceptibility relationships typically involves single agents. However, susceptibility profiles may be affected by multiple drugs. From 1992 through 1996, we studied relationships between drug usage and the susceptibility (only susceptibility rates of greater than or equal to 70%) of Acinetobacter anitratus (baumannii), Enterobacter aerogenes, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens to 22 agents. Linear regression was used to assess usage of each agent vs. susceptibility to it and to all agents. Only relationships with a coefficient of determination of greater than or equal to 0.5 and a negative slope were evaluated and classified as increasing drug use and decreasing susceptibility (up arrow D, down arrow%S) or decreasing drug use and increasing susceptibility (down arrow D, up arrow%S). The mean numbers (range) of drugs associated with a change in susceptibility were 1.7 (0-14) and 0.6 (0-7), respectively, for to, down arrow%S and down arrow D, up arrow%S relationships. Multiple antimicrobials are associated with susceptibility to other drugs; thus, surveillance of these relationships should not be limited to single drugs.
引用
收藏
页码:1017 / 1024
页数:8
相关论文
共 38 条
[1]  
[Anonymous], REP ASM TASK FORC AN
[2]  
ANTIA R, 1996, 36 INT C ANT AG CHEM
[3]  
BALAGUE M, 1991, ANN PHARMACOTHER, V25, P871
[4]  
BALLOW CH, 1992, DIAGN MICROBIOL INFE, V15, P37
[5]   ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
CHOW, JW ;
FINE, MJ ;
SHLAES, DM ;
QUINN, JP ;
HOOPER, DC ;
JOHNSON, MP ;
RAMPHAL, R ;
WAGENER, MM ;
MIYASHIRO, DK ;
YU, VL .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :585-590
[6]   EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA [J].
COHEN, ML .
SCIENCE, 1992, 257 (5073) :1050-1055
[7]   ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES IN PATIENTS WITH CANCER AND NEUTROPENIA [J].
COMETTA, A ;
CALANDRA, T ;
BILLE, J ;
GLAUSER, MP .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) :1240-1241
[8]   ANTIBIOTIC-RESISTANCE IN INTENSIVE-CARE UNIT AREAS [J].
DASCHNER, F ;
LANGMAACK, H ;
WIEDEMANN, B .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1983, 4 (05) :382-387
[9]  
Gaynes R, 1997, CIBA F SYMP, V207, P47
[10]   The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals [J].
Gaynes, R .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (04) :757-&